Product Code: SR1323A605_Report
The global orthopedic implants market size reached US$ 50.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 67.8 Billion by 2028, exhibiting a growth rate (CAGR) of 4.8% during 2023-2028.
An orthopedic implant is a medical device primarily designed for repairing or replacing a deformed or damaged bone, joint, or cartilage. It is made of stainless steel and titanium alloys to provide strength and coated with a plastic layer for serving as an artificial cartilage. It is widely used in spinal fusion surgery for the treatment of back pain as well as for hip and joint replacement. As a result, it finds extensive applications in hospitals, orthopedic clinics, and ambulatory surgical centers across the globe.
Orthopedic Implants Market Trends:
- There is presently a rise in the number of orthopedic operations being performed globally due to increasing traumas, injuries, and accidents. This, along with the growing bone density issues and middle-age bone diseases among individuals, represents one of the driving market factors. Moreover, there is an increase in the utilization of orthopedic implants to treat musculoskeletal across the globe. This, coupled with the rising geriatric population around the world, is propelling the growth of the market. In addition, governments of several countries are extensively investing in healthcare infrastructure, which is positively influencing the market. Besides this, the growing prevalence of orthopedic diseases, such as arthritis and osteoarthritis worldwide, are catalyzing the demand for orthopedic implants. Apart from this, technological advancements in orthopedic implants, such as robot-assisted surgical tools, are strengthening the market growth. Other growth-inducing factors are rapid urbanization, inflating disposable income of individuals and the expanding healthcare industry. Furthermore, major industry vendors are focusing on research and development (R&D) activities to develop bioresorbable implants and internal fixation devices, which is projected to bolster the growth of the market.
Key Market Segmentation:
- IMARC Group provides an analysis of the key trends in each sub-segment of the global orthopedic implants market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, type, biomaterial and end user.
Breakup by Product:
- Reconstructive Joint Replacements
- Knee Replacement Implants
- Hip Replacement Implants
- Extremities
- Spinal Implants
- Spinal Fusion Implants
- Vertebral Compression Fracture (VCF) Devices
- Motion Preservation Devices/Non-Fusion Devices
- Dental Implants
- Root Form Dental Implants
- Plate Form Dental Implants
- Trauma
- Orthobiologics
- Demineralized Bone Matrix (DBM)
- Allograft
- Bone Morphogenetic Protein (BMP)
- Viscosupplementation Products
- Synthetic Bone Substitutes
- Others
- Others
Breakup by Type:
- Knee
- Hip
- Wrist and Shoulder
- Dental
- Spine
- Ankle
- Others
Breakup by Biomaterial:
- Metallic Biomaterials
- Stainless Steel
- Titanium Alloy
- Cobalt Alloy
- Others
- Ceramic Biomaterials
- Polymers Biomaterials
- Others
Breakup by End User:
- Hospitals
- Orthopedic Clinic
- Ambulatory Surgical Centers
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
- The competitive landscape of the industry has also been examined along with the profiles of the key players being Arthrex Inc., Auxein Medical, B. Braun Melsungen AG, CONMED Corporation, Globus Medical Inc., Integra LifeSciences, Johnson & Johnson, Medtronic Plc, Narang Medical Limited, Orthopaedic Implant Company, Smith & Nephew plc, Stryker Corporation and Zimmer Biomet.
Key Questions Answered in This Report:
- 1. What was the size of the global orthopedic implants market in 2022?
- 2. What is the expected growth rate of the global orthopedic implants market during 2023-2028?
- 3. What has been the impact of COVID-19 on the global orthopedic implants market?
- 4. What are the key factors driving the global orthopedic implants market?
- 5. What is the breakup of the global orthopedic implants market based on the product?
- 6. What is the breakup of the global orthopedic implants market based on the type?
- 7. What is the breakup of the global orthopedic implants market based on the biomaterial?
- 8. What are the key regions in the global orthopedic implants market?
- 9. Who are the key players/companies in the global orthopedic implants market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Orthopedic Implants Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Reconstructive Joint Replacements
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Knee Replacement Implants
- 6.1.2.2 Hip Replacement Implants
- 6.1.2.3 Extremities
- 6.1.3 Market Forecast
- 6.2 Spinal Implants
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Spinal Fusion Implants
- 6.2.2.2 Vertebral Compression Fracture (VCF) Devices
- 6.2.2.3 Motion Preservation Devices/Non-Fusion Devices
- 6.2.3 Market Forecast
- 6.3 Dental Implants
- 6.3.1 Market Trends
- 6.3.2 Key Segments
- 6.3.2.1 Root Form Dental Implants
- 6.3.2.2 Plate Form Dental Implants
- 6.3.3 Market Forecast
- 6.4 Trauma
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Orthobiologics
- 6.5.1 Market Trends
- 6.5.2 Key Segments
- 6.5.2.1 Demineralized Bone Matrix (DBM)
- 6.5.2.2 Allograft
- 6.5.2.3 Bone Morphogenetic Protein (BMP)
- 6.5.2.4 Viscosupplementation Products
- 6.5.2.5 Synthetic Bone Substitutes
- 6.5.2.6 Others
- 6.5.3 Market Forecast
- 6.6 Others
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
7 Market Breakup by Type
- 7.1 Knee
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Hip
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Wrist and Shoulder
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Dental
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Spine
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Ankle
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
- 7.7 Others
- 7.7.1 Market Trends
- 7.7.2 Market Forecast
8 Market Breakup by Biomaterial
- 8.1 Metallic Biomaterials
- 8.1.1 Market Trends
- 8.1.2 Key Segments
- 8.1.2.1 Stainless Steel
- 8.1.2.2 Titanium Alloy
- 8.1.2.3 Cobalt Alloy
- 8.1.2.4 Others
- 8.1.3 Market Forecast
- 8.2 Ceramic Biomaterials
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Polymers Biomaterials
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Orthopedic Clinic
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Ambulatory Surgical Centers
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Arthrex Inc.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 SWOT Analysis
- 15.3.2 Auxein Medical
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 B. Braun Melsungen AG
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 SWOT Analysis
- 15.3.4 CONMED Corporation
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Globus Medical Inc.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 Integra LifeSciences
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Johnson & Johnson
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Medtronic Plc
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Narang Medical Limited
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 Orthopaedic Implant Company
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.11 Smith & Nephew plc
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
- 15.3.12 Stryker Corporation
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.12.3 Financials
- 15.3.12.4 SWOT Analysis
- 15.3.13 Zimmer Biomet
- 15.3.13.1 Company Overview
- 15.3.13.2 Product Portfolio
- 15.3.13.3 Financials
- 15.3.13.4 SWOT Analysis